Phase I study of VRCTC-310, a purified phospholipase A2 purified from snake venom, in patients with refractory cancer: safety and pharmacokinetic data

L.A. Marques Da Costa(Hospital São Vicente), Juan C. Cervellino(Universidad de Buenos Aires), Carlos E. Araujo, Roberto A. Díez(Universidad de Buenos Aires), Carlos Martín Molina, Horacio A. Miles
Anti-Cancer Drugs
October 1, 1997
Cited by 26


Related Papers